While coffee’s health benefits are still a topic of debate, most experts agree that staying below 400 mg of caffeine a day—roughly four 8‑ounce cups—keeps intake safe.
Harvard and Tulane University researchers examined extensive survey data on coffee habits and matched it to mortality records. They identified two distinct drinking patterns: those who limited coffee to the morning hours (4 a.m.–11:59 a.m.) and those who consumed it throughout the day, into the afternoon and evening.
Ten years later, the study found that morning coffee drinkers were 16 % less likely to die from any cause compared with non‑coffee drinkers. The effect was even stronger for cardiovascular disease, with a 31 % reduction in risk. No such benefit emerged for all‑day coffee drinkers, suggesting timing, not just quantity, plays a critical role.
Our bodies follow an internal circadian rhythm that governs wakefulness, hormone release, and sleep. The rhythm peaks with cortisol and adrenaline during daylight and drops with melatonin at night. High caffeine intake later in the day can suppress melatonin, disrupting sleep and lowering nocturnal blood pressure—a known factor in cardiovascular risk.
Inflammatory proteins also peak in the morning. Coffee’s anti‑inflammatory properties may counteract this surge, potentially reducing the long‑term damage that drives heart and neurodegenerative diseases.
These findings, while compelling, stem from self‑reported survey data, which can introduce recall bias and social desirability bias. The analysis is correlational, not causal; factors such as shift work—common among late‑day coffee drinkers—may confound results.
Additionally, the groups were uneven: 36 % of participants were morning drinkers, while only 14 % consumed coffee all day. This imbalance adds complexity to statistical interpretation.
In short, the study opens the door for more targeted research on caffeine timing, but it does not yet provide definitive guidance for all coffee lovers.
